What are the central line-associated bloodstream infection rates in pediatric cardiac intensive care units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Cardiac ICU CLABSI Rates

Central line-associated bloodstream infection (CLABSI) rates in pediatric cardiac intensive care units range from 2.3 to 7.8 per 1,000 catheter-days, with recent evidence-based interventions achieving rates as low as 0.98-1.02 per 1,000 catheter-days.

Baseline Rates and Context

The CLABSI burden in pediatric cardiac ICUs is substantial and historically higher than in general pediatric ICUs. Pediatric CLABSI rates are consistently higher than adult rates 1, with neonatal ICU rates ranging from 2.6 to 60 cases per 1,000 central line days in resource-limited settings compared to 2.9 per 1,000 in the USA 1.

For pediatric cardiac ICUs specifically:

  • Pre-intervention baseline rates: 7.8 infections per 1,000 catheter-days 2
  • Post-intervention rates: 2.3 infections per 1,000 catheter-days 2
  • Most recent optimized rates: 0.98-1.02 per 1,000 catheter-days 3

The overall pediatric literature reports CLABSI rates between 3.8 and 11.3 infections per 1,000 catheter days, depending on patient and catheter variables 4.

Why Cardiac ICUs Have Higher Rates

Cardiac ICU patients face unique risk factors that elevate their infection risk:

  • Higher central line utilization ratios compared to general PICUs 5
  • Complex cardiac surgery with higher surgical complexity scores 6
  • Open sternum postoperatively 6
  • Lower body weight and younger age 6
  • Prolonged catheter dwell times 6
  • Multiple concurrent catheters 7

Cardiac ICUs demonstrate significantly higher central-line utilization (p < 0.001) compared to general PICUs, though overall CLABSI prevalence across PICU types remains similar at approximately 1.37 events per 1,000 central-line days 5.

Clinical Impact and Mortality

The consequences of CLABSI in pediatric cardiac patients are severe:

  • Mortality rate: 11% in BSI group versus 2% in non-BSI group 6
  • Neonatal mortality: 21% related to bloodstream infections 1
  • Increased length of stay: 23 days in neonates 1
  • Neurodevelopmental impairment risk significantly increases in very low birthweight infants with one or more infection episodes 1

Temporal Risk Patterns

CLABSI risk is strongly phase-dependent and increases dramatically with catheter dwell time 8:

  • Days 0-14: Baseline risk
  • Days 15-22: 4.33-fold increased odds (95% CI 1.89-9.92)
  • Days ≥23: 11.71-fold increased odds (95% CI 3.22-42.62)

This temporal pattern supports time-triggered line-necessity reviews, particularly after 14 days of catheter dwell 8.

Catheter Type and Site Considerations

Right internal jugular insertion is associated with lower infection risk (adjusted OR 0.34; 95% CI 0.14-0.81) compared to femoral access 8.

In young pediatric cardiac patients (<1.5 years), tunneled femoral central venous catheters demonstrated one-third the odds of CLABSI (OR 0.31; 95% CI 0.13-0.78) compared to upper extremity PICCs, with rates of 2.38 versus 7.14 per 1,000 line days (p = 0.004) 9.

Achievable Benchmarks with Interventions

Comprehensive bundle interventions can reduce CLABSI rates by 60-70% 1. The most successful documented interventions include:

  • Baseline: 10.5 per 1,000 catheter-days
  • Post-intervention: 3.6 per 1,000 catheter-days 7

In multinational settings, bundle implementation reduced rates from 15.34 to 2.23 per 1,000 catheter-days over 29 months 7.

The most recent evidence demonstrates that with novel risk-stratification screening tools and targeted interventions, pediatric cardiac ICUs can achieve rates of 0.98-1.02 per 1,000 catheter-days 3, representing a 46-47% reduction from already-optimized baseline rates of 1.83 per 1,000 catheter-days.

Common Pitfalls

  • Assuming maintenance bundle compliance alone prevents CLABSI: Unit-level analysis shows no direct association between maintenance bundle compliance rates and CLABSI prevalence 5, suggesting patient-specific factors require equal attention
  • Ignoring temporal risk escalation: Failing to implement time-triggered reviews after 14 days misses the critical window when infection risk quadruples 8
  • Underestimating cardiac ICU-specific risks: The higher central-line utilization and patient complexity in cardiac ICUs necessitates more aggressive prevention strategies than general PICUs 5

References

Research

The Association of Central-Line-Associated Bloodstream Infections With Central-Line Utilization Rate and Maintenance Bundle Compliance Among Types of PICUs.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2016

Research

Durable Central Venous Access for Pediatric Cardiac Patients: Secondary Analysis of a Single-Center, Retrospective Cohort Study, 2015-2021.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.